RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Exploring the effect of NK-cell related molecules on the prognosis and tumor microenvironment of gastric cancer patients: Evidence from large sample populations.
Exploring the effect of NK-cell related molecules on the prognosis and tumor microenvironment of gastric cancer patients: Evidence from large sample populations.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的发现有助于更全面地理解 NK 细胞在胃癌中的作用,并突出 MUCL1 作为一个有前景的治疗靶点。
自然杀伤(NK)细胞在抗肿瘤免疫中发挥重要作用,其参与已在多种癌症中得到证实。然而,仍需更深入地了解NK细胞影响胃癌进展的机制。
我们利用癌症基因组图谱(TCGA)数据库获取胃癌患者的转录谱、临床信息和突变数据。所有针对这些公开数据的分析均使用R软件及相关软件包进行。
我们使用多种算法评估胃癌样本中的肿瘤微环境。我们进行了差异表达分析,以确定与NK细胞相关的基因。利用这些数据,我们开发了一个包含三个关键NK细胞相关基因的预后模型:MAB21L2、ARPP21和MUCL1。该模型在训练组和验证组中显示出强大的预测性能。一致地,根据我们的模型被识别为高风险的患者具有更差的总生存率。为了进一步阐明高风险和低风险患者之间的生物学差异,我们进行了聚焦于生物学通路和免疫相关因素的富集分析。此外,我们观察到较高的风险评分与治疗无反应性之间存在相关性。有趣的是,发现高风险患者可能对axitinib更敏感。由于MUCL1在该模型中的潜在作用,我们选择其进行进一步研究。虽然MUCL1 mRNA水平在胃癌和配对正常组织中均升高,但使用Human Protein Atlas数据库进行的蛋白表达分析显示,肿瘤组织内MUCL1蛋白水平降低。
Natural killer (NK) cells play a significant role in anti-tumor immunity, and their involvement has been documented in various cancers. However, a deeper understanding of the mechanisms by which NK cells influence gastric cancer progression remains necessary.
We utilized the Cancer Genome Atlas (TCGA) database to acquire transcriptional profiles, clinical information, and mutation data for gastric cancer patients. R software and associated packages were employed for all analyses of this publicly available data.
We used multiple algorithms to evaluate the tumor microenvironment in gastric cancer samples. We performed differential expression analysis to pinpoint genes related to NK cells. Utilizing this data, we developed a prognostic model featuring three crucial NK cell-related genes: MAB21L2, ARPP21, and MUCL1. This model showed strong predictive performance in the training and validation groups. Consistently, patients identified as high-risk according to our model had worse overall survival rates. To further elucidate the biological differences between high-risk and low-risk patients, we performed enrichment analyses focusing on biological pathways and immune-related factors. Additionally, we observed a correlation between higher risk scores and non-responsiveness to treatment. Interestingly, high-risk patients were found to be potentially more sensitive to axitinib. We selected MUCL1 for further investigation due to its potential role in the model. While MUCL1 mRNA levels were elevated in both gastric cancer and paired normal tissues, protein expression analysis using the Human Protein Atlas database revealed a decrease in MUCL1 protein levels within tumor tissues.
Our findings contribute to a more comprehensive understanding of the role of NK cells in gastric cancer and highlight MUCL1 as a promising therapeutic target.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。